Elsevier

JACC: Cardiovascular Imaging

Volume 3, Issue 11, November 2010, Pages 1158-1165
JACC: Cardiovascular Imaging

Technology on the Verge of Translation
Towards Real-Time Intravascular Endoscopic Magnetic Resonance Imaging

https://doi.org/10.1016/j.jcmg.2010.08.014Get rights and content
Under an Elsevier user license
open archive

Fast, minimally invasive, high-resolution intravascular imaging is essential for identifying vascular pathological features and for developing novel diagnostic tools and treatments. Intravascular magnetic resonance imaging (MRI) with active internal probes offers high sensitivity to pathological features without ionizing radiation or the limited luminal views of conventional X-rays, but has been unable to provide a high-speed, high-resolution, endoscopic view. Herein, real-time MRI endoscopy is introduced for performing MRI from a viewpoint intrinsically locked to a miniature active, internal transmitter–receiver in a clinical 3.0-T MRI scanner. Real-time MRI endoscopy at up to 2 frames/s depicts vascular wall morphological features, atherosclerosis, and calcification at 80 to 300 μm resolution during probe advancement through diseased human iliac artery specimens and atherosclerotic rabbit aortas in vivo. MRI endoscopy offers the potential for fast, minimally invasive, transluminal, high-resolution imaging of vascular disease on a common clinical platform suitable for evaluating and targeting atherosclerosis in both experimental and clinical settings.

Key Words

atherosclerosis
calcium
endoscopy
intravascular
magnetic resonance imaging

Abbreviations and Acronyms

CT
computed tomography
FA
flip angle
FOV
field of view
MRI
magnetic resonance imaging
OD
outer diameter
RF
radiofrequency
SNR
signal-to-noise ratio

Cited by (0)

Drs. Sathyanarayana and Schär are currently full-time employees of GE Healthcare, Bangalore, India, and Philips Healthcare, respectively. Dr. Sathyanarayana was a graduate student trainee and not a GE employee at the time of the work. Dr. Schär is a Visiting Scientist at Johns Hopkins University. This work was supported by National Institutes of Health grants R01 EB007829 and R01 HL090728 (to Dr. Bottomley), and R21/R33HL89029 (to Dr. Kraitchman). Drs. Bottomley and Sathyanarayana are coinventors of a patent on the technology filed by Johns Hopkins University and licensed to SurgiVision, Inc., a Johns Hopkins University start-up company with which Dr. Bottomley has a financial relationship that is managed in accordance with the University's conflict-of-interest policies. Drs. Schär and Kraitchman report that they have no relationships to disclose.

Section Editor: Amir Lerman, MD